Skip to content
StockMarketAgent
Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

FRA/0PT stock hub

FRA/0PT has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

FRA/0PTis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
477.3M
Frankfurt Stock Exchange
Market data

Price

Recent price action with selectable time range.

FRA/0PTFRA/0PT
—
Loading chart…
In the news

Latest news · FRA/0PT

Recent company headlines from major financial publishers.

Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window—
EPS estimate—
Revenue estimate—
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E7.2
P25 n/aP50 n/aP75 n/a
Trailing P/En/a
P25 n/aP50 n/aP75 n/a
ROE-40.3
P25 n/aP50 n/aP75 n/a
ROIC-4,795.6
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All FRA/0PT market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
163
Groups with data
11
Currency
USD
Showing 163 of 163 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
Ireland
Country code
DE
Employees
67
Employees Change
-10%
Employees Change Percent
-5.78
Enterprise value
EUR 203.9M
Exchange
Frankfurt Stock Exchange
Financial currency
USD
First seen
2026-05-10
Industry
Biological Products, Except Diagnostic Substances
Last refreshed
2026-05-10
Market cap
EUR 477.3M
Price
EUR 8.91
Price currency
EUR
Rev Per Employee
750,020.33x
Sic
2836
Symbol
fra/0PT
Website
https://www.prothena.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

8
MetricValue
Earnings Yield
-27.47%
EV Earnings
-1.55x
EV/FCF
-2.89x
EV/Sales
4.14x
FCF yield
-14.8%
Forward P/E
7.19x
P/B ratio
1.76x
P/S ratio
9.5x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

14
MetricValue
EBIT Margin
-160.84%
EBITDA Margin
-159.36%
Gross margin
-132.74%
Gross Profit
EUR -66.7M
Net Income
EUR -131.1M
Pretax Margin
-184.21%
Profit Margin
-260.92%
Profit Per Employee
EUR -2M
ROA
-13.78
Roa5y
-12.17
ROCE
-29.36
ROE
-40.3
Roe5y
-22.54
ROIC
-4,795.6

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

8
MetricValue
Cagr10y
-12.3%
Cagr1y
41.43%
Cagr3y
-49.93%
Cagr5y
-14.51%
Revenue Growth
-58x
Revenue Growth Q
1,706.37x
Revenue Growth3 Y
1.8x
Revenue Growth5 Y
131.47x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

18
MetricValue
Asset Turnover
EUR 0.14
Assets
EUR 303.5M
Cash
EUR 285.7M
Current Assets
EUR 287.6M
Current Liabilities
EUR 27.6M
Debt
EUR 6.6M
Debt Equity
EUR 0.02
Debt FCF
EUR -0.09
Equity
EUR 271.1M
Liabilities
EUR 32.3M
Long Term Assets
EUR 15.8M
Long Term Liabilities
EUR 4.8M
Net Cash
EUR 279.1M
Net Cash By Market Cap
EUR 58.48
Net Cash Growth
-21.07%
Net Debt Equity
EUR -1.03
Tangible Book Value
EUR 271.1M
Tangible Book Value Per Share
EUR 5.11

Liquidity

Current-asset coverage and working-capital efficiency metrics.

5
MetricValue
Current ratio
10.43
Net Working Capital
EUR -17.2M
Quick ratio
10.13
Working Capital
EUR 266M
Working Capital Turnover
EUR 0.14

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

35
MetricValue
10Y total return
-73.07%
1Y total return
41.4%
200-day SMA
7.88
3Y total return
-87.45%
50-day SMA
8.38
50-day SMA vs 200-day SMA
50over200
5Y total return
-54.32%
All Time High
71
All Time High Change
-87.45%
All Time High Date
2015-11-27
All Time Low
3.86
All Time Low Change
130.78%
All Time Low Date
2025-05-30
ATR
0.24
Ch YTD
12.05
High
8.91
High52
9.76
High52 Date
2026-04-28
High52ch
-8.77%
Low
8.91
Low52
3.86
Low52 Date
2025-05-30
Low52ch
130.78%
Ma50ch
6.31%
Price vs 200-day SMA
12.99%
RSI
51.15
RSI Monthly
39.26
RSI Weekly
57.56
Sharpe ratio
0.8x
Sortino ratio
1.25
Total Return
0%
Tr YTD
12.05
Tr1m
2.39%
Tr1w
-0.27%
Tr3m
21.2%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
EUR -80.8M
Operating margin
-160.8

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

5
MetricValue
Float
39,650,349%
Shares Insiders
20.07%
Shares Institutions
86.27%
Shares Qo Q
0.52%
Shares Yo Y
-0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

49
MetricValue
Adjusted FCF
EUR -99.8M
Average Volume
0.45x
Bv Per Share
5.11
CAPEX
EUR -83,261
Ch10y
-73.07
Ch1m
2.39
Ch1w
-0.27
Ch1y
41.4
Ch3m
21.2
Ch3y
-87.45
Ch5y
-54.32
Ch6m
-0.47
Change
-4.48%
Change From Open
-0.02
Close
9.33
Days Gap
-4.5
Depreciation Amortization
725,855.5
Earnings Date
2026-05-07
EBIT
EUR -80.8M
EBITDA
EUR -80.1M
EPS
EUR -2.44
F Score
2
FCF
EUR -70.6M
FCF EV Yield
-34.65x
Financing CF
-6,103,190
Fiscal Year End
December
Founded
2,012
Income Tax
EUR 38.5M
Investing CF
-83,261
Is Primary Listing
0
Last Earnings Date
2026-05-07
Last Report Date
2026-03-31
Ma150
8.27
Ma150ch
7.66%
Ma20
9.07
Ma20ch
-1.78%
Net CF
-76,732,633
Next Earnings Date
2026-05-13
Open
8.91
Ppne
7,929,292.7
Price Date
2026-05-08
Ptbv Ratio
1.76
Relative Volume
20x
Revenue
50,251,362x
SBC By Revenue
58x
Share Based Comp
29,146,484
Tax By Revenue
76.7x
Tr6m
-0.47%
Volume
0
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does FRA/0PT pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/0PT stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+41.4%
S&P 500 1Y: n/a
3Y total return
-87.5%
S&P 500 3Y: n/a
5Y total return
-54.3%
S&P 500 5Y: n/a
10Y total return
-73.1%
S&P 500 10Y: n/a
Ownership

Who owns FRA/0PT?

Insider, institutional, and short-interest positioning.

Institutional ownership
+86.3%
Share of float held by funds and institutions
Insider ownership
+20.1%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
-0.0%
Negative means the company is buying back shares.
Technical

FRA/0PT momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
51.2
Neutral momentum band
Price vs 200-day MA
+13.0%
50/200-day relationship not available
Beta (5Y)
n/a
Sensitivity to the broader market
Sharpe ratio
0.80
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About FRA/0PT

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/0PT stock rating?

fra/0PT is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/0PT analysis?

The full report lives at /stocks/fra/0PT/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/0PT?

The latest report frames fra/0PT around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/0PT page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.